(19)
(11) EP 2 346 387 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
01.05.2013 Bulletin 2013/18

(45) Mention of the grant of the patent:
13.03.2013 Bulletin 2013/11

(21) Application number: 09785459.0

(22) Date of filing: 07.08.2009
(51) International Patent Classification (IPC): 
A61B 5/024(2006.01)
A61B 5/145(2006.01)
 A61B 5/08(2006.01)
(86) International application number:
PCT/GB2009/050989
(87) International publication number:
WO 2010/015863 (11.02.2010 Gazette 2010/06)

(54)

BLOOD ANALYSIS

BLUTANALYSE

ANALYSE DE SANG

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

(30) Priority: 08.08.2008 GB 0814419

(43) Date of publication of application:
27.07.2011 Bulletin 2011/30

(73) Proprietor: To Health Limited
London SE1 1LB (GB)

(72) Inventors:
  • ORBACH, Tuvi
    Greater London NW11 0SA (GB)
  • STOCKS, John Rupert
    Harpenden Hertfordshire AL5 2RW (GB)

(74) Representative: Mansfield, Peter Turquand 
Coller IP Management Fugro House Hithercroft Road
Wallingford, Oxon OX10 9RB
Wallingford, Oxon OX10 9RB (GB)


(56) References cited: : 
EP-A- 0 712 602
 JP-A- 2007 319 246
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).